NCT07267091

The Burden of Lupus in Canada From a Patient Perspective: A Canadian Real-World PROxy Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 88 (actual)
• Sponsor: PeriPharm · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study aims to capture the Canadian patient experience, burden, barriers, and treatment preferences. The findings will generate real-world evidence to support patient-centered care and guide healthcare providers, researchers, and decision-makers in improving support and treatment for people living with lupus.

Detailed description

Lupus Canada will distribute an invitation to participate in the study through their mailing list, website, social networks providing a link to the questionnaire. Their mailing list database comprises about 8,000 individuals, including patients. Lupus Canada will reach out to the lupus community to inform them about their eligibility to participate in the study. Those meeting the eligibility criteria will be invited to sign the informed consent form (ICF) and complete all the study questionnaires on the PROxy web-based platform. For any questions, interested participants will have access to the contact information of the PROxy team, and a designated team member will communicate with participants by phone to answer all questions.

Conditions

• Lupus
• Lupus Arthritis
• Lupus Arthritis, Systemic Lupus Erythematosus
• Quality of Life (QOL)

Interventions

Type	Name	Description
OTHER	No Intervention: Observational Cohort	No specific intervention is assess in this study. Observational cohort.

Timeline

• Start date: 2025-11-03
• Primary completion: 2026-01-23
• Completion: 2026-01-23
• First posted: 2025-12-05
• Last updated: 2026-01-29

Locations

1 site across 1 country: Canada